SPON2, IFI44, CD68, and CD206 were highly expressed in high-grade gliomas, and SPON2 was positively correlated with CD68 rather than CD206, whereas IFI44 was positively correlated with both CD68 and CD206 expression. This evidence concerns the gene MRC1 and central nervous system cancer.